NCT03680326View on ClinicalTrials.gov

Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

February 2, 2015

Primary Completion Date

March 22, 2018

Study Completion Date

April 14, 2018

Conditions
Vitreomacular Interface
Interventions
DEVICE

OCT

only OCT

All Listed Sponsors
lead

Hospital Hietzing

OTHER

NCT03680326 - Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter